- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03019380
A Clinical Trial to Test the Saftey and Success Rate for a Cerrumen Cleaning Device - "Wondertip".
Testing the Effectivness and Safety of the Wondertip
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cerumen is ear wax, a combination of dead skin cells of the external ear canal, sebaceous glands secretions and ceruminous sweat glands secretions. Cerumen exists in a range of people but sometimes it become an obstacle to patients or caregivers. Cerumen may accumulate in the external ear canal and cause discomfort to the patient, sensation ofobtuseness and conductive hearing loss. Patients who use hearing aids may suffer from problems wearing them, and sometimes the cerumen may plug the inner part of the hearing aid or the ventilation channel of the ear phone.
For caregivers, cerumen may poses a diagnostic challenge, by concealing part of the external ear canal and tympanic membrane, thus making it difficult to observe the middle ear. cerumen my affect the results of audiometric tests, ABR tests, Otoacustic Emission tests and in conducting tympanometric tests. All of which may result in false results. The incidence of cerumen is estimated to be betwean 7 to 35% of the general population.
There are few options to evacuate the cerumen, but they usually require skill and the use of otology microscope. It mays casue discomfort or pain, and even trauma to the external ear canal or the tympanic membrane. A device which does not require a special skill or equipment may have a advantage, especially for the general practioner doctor.
The Wondertip is an Israeli patent, made of silicone with a coil like end, targeted to evacuate the cerumen in a safe and effective manner. The coil is gently inserted to the ear canal, grasps and evacuates the cerumen.
The purpose of the trial is to investigate the safety and efficacy of the Wondertip. A second purpose is to messure external ear canal depth.
Each candidate which will present with cerumen impaction will recieve a detailed explanation regarding the trial. If the patient agrees, and signs a concent form, a short interview will take place by the doctor. An evacuation of the cerumen will be attempted by the same doctor with the Wondertip. Further the doctor will document details regarding the safety and efficacy of the procedure.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ehud Katzanel, Dr
- Phone Number: 972-8-9441649
- Email: udika@clalit.org.il
Study Contact Backup
- Name: Noam Bartov, Dr
- Phone Number: 972547895064
- Email: noam.bartov@clalit.org.il
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients over 1 year old who have cerumen impaction.
Exclusion Criteria:
- external ear infection
- chronic otitis media with perforation of the tympanic membrane
- past ear surgery
- otorrhea
- inflamation of the auricle or the periauricular region
- temporal bone neoplasm
- deafness in the contralateral ear (single sided deafness).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Impacted cerumen
removing cerumen from external ears of patients with impacted cerumen, obscuring the canal and the tympanic membrane.
|
The wondertip will be coiled into the external ear canal with the purpose of grasping and evacuating the cerumen.
Following the evacuation, the depth of the external ear canal will be messured.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
view of the tympanic membrane
Time Frame: 10 minutes
|
how much of the tympanic is visible after using the Wondertip
|
10 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ehud Katzanel, Dr, Kaplan Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0125-16-KMC-CTIL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on External Ear Disorder
-
Laboratorios Osorio de Moraes Ltda.Unknown
-
Fatima ElmougiCompletedEar Deformity ExternalEgypt
-
Pontificia Universidad Catolica de ChileCompletedExternal Causes of Morbidity and Mortality | External Causes of Morbidity (V00-Y99)
-
Methodist Health SystemActive, not recruitingExternal Ventricular DrainUnited States
-
Yaakov BeilinTerminatedExternal Cephalic VersionUnited States
-
Icahn School of Medicine at Mount SinaiTerminated
-
Assistance Publique - Hôpitaux de ParisNeuroresp, Reference centre Syndrome d'OndineRecruitingExternal Mechanical Ventilatory SupportFrance
-
Ningbo No. 1 HospitalCompletedColonoscopy | Predictive Model | External ValidationChina
-
University of Wisconsin, MadisonRecruitingExternal Ventricular Drain | Intracranial PressureUnited States
-
Genton Graf LaurenceCompletedExternal Causes of Morbidity and MortalitySwitzerland